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The ubiquitin ligase Smad ubiquitination regulatory factor 1 (Smurf1) targets many proteins includ-
ing Smad1/5 for ubiquitin-dependent proteasomal degradation. However, how Smurf1 is degraded
remains unclear. Here we show that REGc, an activator for the 20S proteasome-mediated protein
degradation, interacts with Smurf1 and mediates its degradation. We provide evidence that deple-
tion of REGc stabilizes Smurf1 whereas overexpression of REGc promotes the degradation of
Smurf1. Interestingly both Smurf2 and Smurf1 are destabilized by the REGc proteasome while the
other members of Neural precursor cell-expressed developmentally downregulated gene 4 family
were not affected. More importantly, we found that the REGc proteasome-mediated degradation
of Smurf1 results in degradation of Smad5. These ﬁndings reveal that the REGc-proteasome targets
a ubiquitin ligase for protein degradation.
Structured summary:
MINT-7894509: CKIP (uniprotkb:Q53GL0) binds (MI:0407) to Smurf1 (uniprotkb:Q9HCE7) by pull down
(MI:0096)
MINT-7894494: REG gamma (uniprotkb:P61289) binds (MI:0407) to Smurf1 (uniprotkb:Q9HCE7) by pull
down (MI:0096)
MINT-7894523, MINT-7894543, MINT-7894481: REG gamma (uniprotkb:P61289) physically interacts
(MI:0915) with Smurf1 (uniprotkb:Q9HCE7) by anti tag coimmunoprecipitation (MI:0007)
MINT-7894558: Smurf1 (uniprotkb:Q9HCE7) physically interacts (MI:0915) with REG gamma (uni-
protkb:P61289) by two hybrid (MI:0018)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The proteasome system is one of the most important systems
for protein degradation in eukaryotes and regulates cellular pro-
cesses including cell cycle, transcription, cell signaling, cell death
and immune responses [1]. The proteasome is a large multi-sub-
unit proteolytic enzyme composed of a cylindrical 20S core particle
and three proteasomal activators, PA700 (also called 19S proteaso-
mal activator), PA28 (also called 11S proteasomal activator, REG)
and PA200. These subunits composed two different protein degra-chemical Societies. Published by E
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lq@nic.bmi.ac.cn (L. Zhang).dation systems. The 19S regulatory particle-20S proteasome com-
plex mediates the substrate proteins for degradation in an
ubiquitin- and ATP-dependent process [2–4]. By contrast, the 11S
proteasome activator (i.e. REG)-20S proteasome complex mediates
protein degradation independent of ATP and ubiquitin.
REGc (also known as PA28c, PSME3, or Ki antigen) belongs to
the REG of 11S family proteasome activators that has been shown
to bind and activate 20S proteasome [5,6]. Of the three REG family
members, REGa can form either homoheptamers or heterohepta-
mers with REGb throughout the cells to participate in MHC class I
antigen presentation [7]. In contrast, REGc resides primarily in
the nucleus in a homoheptamer form, and its biological functions
have not been fully characterized. REGc has been reported to en-
hance the cleavage after basic amino acid residues and selectively
activate the trypsin-like catalytic subunit of the 20S proteasome
[8]. Recent ﬁndings showed that that REGc not only stimulates pro-
teasomal hydrolysis of small peptide model substrates [5,9], but
also target intact cellular proteins for proteasomal degradationlsevier B.V. All rights reserved.
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dependent kinases, p21Cip1, p16INK4a and p19ARF for degradation.
Consistent with this regulation, REGc is implied to have a
regulatory role in cell cycle transition and cell proliferation, as
REGc-deﬁcient mice have signiﬁcantly reduced body size and
REGc-deﬁcient embryonic ﬁbroblasts have impeded entry from G
to S phase in the cell cycle [13,14]. Moreover, REGc enhances the
MDM2-mediated ubiquitination and proteasomal degradation of
tumor suppressor p53, inhibiting p53 accumulation and apoptosis
after DNA damage [15]. Accordantly, embryonic ﬁbroblasts of REGc
nullizygous mice demonstrate spontaneous apoptosis and G1 ar-
rest. In addition, REGc also activates the ubiquitin-independent
degradation of steroid receptor coactivator-3 (SRC-3, also known
as AIB1), an oncoprotein which is often overexpressed in different
cancer types including breast, prostate, ovarian, pancreatic and gas-
tric cancers [16–19], and hepatitis C virus (HCV) core proteins as
well as pituitary tumor-transforming 1 (PTTG1) [20,21]. Therefore,
REGc possesses the ability to induce the degradation of both tumor
suppressors and, oncogenic proteins.
Smad ubiquitination regulatory factor 1 (Smurf1) belongs to the
homologous to E6AP C-terminus (HECT) domain-type ubiquitin-
protein ligase (E3) and plays a pivotal role in maintenance of bone
homeostasis, control of cell polarity, and regulation of embryonic
development through targeting BMP-Smad, Wnt and RhoA signal-
ling proteins for ubiquitination and degradation [22–25]. However,
how Smurf1 itself is degraded remains largely unclear. To better
understand the regulatory mechanisms of Smurf1, we performed
a yeast two-hybrid screening for its new interacting proteins, using
the substrate-recognizing WW domains as bait. One of the preys
encodes REGc and the interaction was validated in mammalian
cells. Depletion of REGc stabilizes Smurf1 whereas overexpression
of REGc promotes the degradation of Smurf1. Our ﬁndings provide
the ﬁrst evidence that the REGc-proteasome can directly target a
ubiquitin ligase for degradation and implicate how Smurf1 was de-
graded by the proteasome.2. Materials and methods
2.1. Plasmid constructs, antibodies and reagents
Full-length, truncated, and point mutations of Smurf1, Smurf2,
REGc, Smad1, Smad3, Smad4, Smad5 were constructed by insert-
ing PCR ampliﬁed fragments into the related vectors. Detailed con-
struct information is available upon request. 6Myc-Smurf1 wild-
type, 6Myc-Smurf1-C699A and Flag-Smurf1 were provided by Dr.
Kohei Miyazono. The protein synthesis inhibitor cycloheximide
(CHX) was purchased from Sigma. Monoclonal anti-Flag antibody
was purchased from Sigma, anti-HA antibody from Roche, anti-
Myc antibody from MBL, anti-Smurf1 and anti-Smurf2 antibodies
were purchased from Abcam. The following antibodies were ob-
tained from Santa Cruz Biotechnology: antibodies against GAPDH
(6C5) and secondary antibodies.
2.2. Cell culture, immunoprecipitation and immunoblotting
Human embryonic kidney HEK293T cells, human breast cancer
MCF7 cells were cultured in DMEM medium (Hyclone) containing
10% foetal bovine serum (FBS; Hyclone). Mammalian cells were
transiently transfected with LipofectAMINE 2000 (Invitrogen) in
accordance with the manufacturer’s instructions. Cells were pre-
pared in HEPES lysis buffer (20 mM HEPES, pH 7.2, 50 mM NaCl,
0.5% Triton X-100, 1 mM NaF, and 1 mM DTT) supplemented with
protease inhibitors after 36 h posttransfection. Immunoprecipita-
tions were performed using primary antibody and protein A/G-
agarose beads at 4 C. Lysates and immunoprecipitates were exam-ined using the indicated primary antibodies and then secondary
antibody, followed by detection with SuperSignal chemilumines-
cence kit (Pierce).
2.3. RNA interference
The knockdown of REGc or Smurf1 was performed by transfec-
tion of MCF7 cells for 48 h with siRNA duplex targeting human
REGc (50-GAAUCAAUAUGUCACUCUAUU-30), or Smurf1 (50-GCAUC-
GAAGUGUCCAGAGAAG-30), with on-target negative control siRNA
Oligo Duplex (50-UUCUCCGAACGUGUCACGU-30) as controls.
2.4. Real-time RT-PCR
Real-time quantitative PCR was performed as described previ-
ously [26]. Reactions were done in triplicate, and relative amounts
of cDNA were normalized to GAPDH. Primers used were as follows:
Smurf1 F, 50-CTACCAGCGTTTGGATCTAT-30 and Smurf1 R, 50-
TGTCTCGGGTCTGTAAACT-30; REGc F, 50-ATCCATGACCTAACTCA-
GATCCA-30; and REGc R, 50-CCCACATTTTGACCGTGTTACA-30. F
and R represents forward and reverse primer, respectively.
2.5. Yeast two hybrid
Yeast two-hybrid screening was performed with the Pro-
QuestTM two-hybrid system (Invitrogen, CA) as we described [27].
2.6. In vitro proteolytic assay
Bacteria-expressed GST-REGc was bound to glutathione beads,
and the GST tag was cleaved by thrombin in PBS [pH 7.2] at room
temperature overnight, and then the REGc protein was puriﬁed. In
the in vitro proteolytic system, 20 ng of His-Smurf1 or His-CKIP-1
protein was incubated with 0.25 lg 20S proteasome (from Boston
Biochem) and 1 lg REGc in 100 ll reaction buffer (20 mM HEPES
[pH 7.5], 100 mM KCl, 0.5 mM EDTA, and 10% glycerol) at 30 C
for 30 min, and analyzed by immunoblotting.
2.7. GST pull-down assay
To detect the direct binding of Smurf1 with REGc, bacteria-ex-
pressed GST, GST-REGc or GST-CKIP-1 proteins were immobilized
on glutathione-Sepharose 4B beads (Amersham), and then incu-
bated with His-Smurf1 for 8 h at 4 C under rotation. Beads were
washed with GST binding buffer (100 mM NaCl, 50 mM NaF,
2 mM EDTA, 1% NP-40 and protease inhibitor cocktail) and proteins
were eluted, followed by immunoblotting.3. Results
3.1. Smurf1 associates with REGc in vivo and in vitro
To identify new Smurf1-interacting proteins, we performed a
yeast two-hybrid (Y2H) screening assay with the WW domains
of Smurf1 (aa 236–340) as the bait in the human adult brain li-
brary. One of the positive clones encoded the full-length REGc, a
member of 11S proteasome activator family (Fig. 1A). We exam-
ined the interaction of Smurf1/REGc in vitro and in vivo. In an
in vivo experiment, Flag-tagged Smurf1 and Myc-tagged REGc
were cotransfected into MCF7 human breast cancer cells, and co-
immunoprecipitation (Co-IP) assays revealed an association be-
tween Smurf1 and REGc (Fig. 1B). In an in vitro experiment, GST-
REGc protein was used to pull-down His-Smurf1 protein while
the GST-CKIP-1 (a known interesting protein with Smurf1 [28])
successfully precipitated down the His-Smurf1 protein (Fig. 1C).
Fig. 1. Smurf1 associates with REGc in vivo and in vitro. (A) The bait and the prey regions of Smurf1 and REGc by yeast two-hybrid screening are shown schematically. (B) Co-
immunoprecipitation (Co-IP) of Smurf1 and REGc. Myc-REGc and Flag-Smurf1 were transfected into MCF7 cells, and cell lysates were immunoprecipitated with anti-Flag
antibody and all samples were analyzed by immunoblotting (IB). Lys, lysate; IP, immunoprecipitate. (C) Direct interaction between His-Smurf1 and GST-REGc is revealed by
GST pull-down assays. Input and pull-down samples were both subjected to immunoblotting with anti-GST and anti-His antibodies. Input represents 10% of that used for
pull-down. The interaction between His-Smurf1 and GST-CKIP-1 was as a positive control.
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in vivo and in vitro.
3.2. REGc negatively regulates the protein stability of Smurf1
Smurf1 contains an N-terminal C2 domain, two central WW do-
mains and a catalytic HECT domain at the C-terminus. The WW do-
mains of Smurf1 mediate the interaction with most of its known
substrates such as Smad1/5, MEKK2, RhoA, Princkle1 and TRAFs
through the PY motif (PPxY or PxxY, x represents any amino acid).
The fact that REGc interacts with the Smurf1 WW domains
(Fig. 1A) prompted us to speculate whether REGc was a potential
substrate of Smurf1. Overexpression of Smurf1 had no signiﬁcant
effect on the steady-state level of REGc, although it signiﬁcantly
decreases the levels of Smad5 (Fig. 2A). This result implies that
REGc might be not a substrate of Smurf1. Sequence analysis
showed that unlike the well-deﬁned Smurf1 substrates, REGc does
not contain a typical PY motif. Considering that REGc is a member
of 11S proteasome activators that is implicated in proteasomal
degradation, we attempted to detect whether REGc was involved
in Smurf1 degradation. Overexpression of REGc resulted in a
reduction of endogenous Smurf1 in a dose-dependent manner
(Fig. 2B, left). As the positive control, the protein level of p21 was
decreased in the presence of ectopic REGc, consistent with previ-
ous reports [11,12]. Real-time RT-PCR experiments showed that
REGc did not change the mRNA level of Smurf1 (Fig. 2B, right).
Depletion of endogenous REGc by transfection of REGc-speciﬁc
siRNA resulted in an increase in the steady-state levels of endoge-
nous Smurf1 compared with the cells transfected with control siR-
NA (Fig. 2C, left). Again, real-time RT-PCR analysis demonstrated
that the mRNA level of Smurf1 was not altered by REGc depletion
(Fig. 2C, right), indicating that REGc negatively regulates the pro-
tein stability of Smurf1 rather than its mRNA expression. The effect
of REGc on Smurf1 was through the proteasome pathway as treat-ment with MG132, a potent proteasome inhibitor, blocked this
downregulation (Fig. 2D).
3.3. REGc promotes the ubiquitin- and ATP- independent degradation
of Smurf1
A key characteristic of the HECT type ubiquitin ligases is a con-
served cysteine (Cys) residue close to the C-terminus that forms an
intermediate thioester bond with the Glycine 76 of ubiquitin be-
fore catalysing the ubiquitination of substrate. This conserved
Cys residue is essential for both the substrate ubiquitination and
the ligase self-ubiquitination [29]. To test whether the active Cys
site-mediated thioester formation is required for proteasomal deg-
radation of Smurf1, we generated a catalytic inactive mutant
C699A at the conserved active site, and examined the effect of
REGc on the stability of this mutant. As shown in Fig. 2E, overex-
pression of REGc also resulted in a signiﬁcant downregulation of
Smurf1-C699A mutant, which effect was comparable with that of
Smurf1 wild-type, suggesting that REGc promoted the turnover
of Smurf1 independently of its self-ubiquitination.
To gain direct insights on whether REGc mediated Smurf1 deg-
radation independently of ubiquitin and ATP, we detected the abil-
ity of REGc to promote cell-free proteolysis. GST-tagged REGc
protein was bacterially expressed and puriﬁed, followed by re-
moval of the GST tag. His-tagged Smurf1 protein was also bacteri-
ally expressed, puriﬁed and used as the degradation substrate in an
in vitro proteolysis system. Incubation of the latent 20S protea-
some or REGc alone had no signiﬁcant effects on Smurf1 level
(Fig. 2F, lanes 2 and 3). By contrast, combination of REGc and the
20S proteasome resulted in a dramatic turnover of Smurf1 protein
in the absence of ubiquitin and ATP (Fig. 2F, lane 4), indicating that
REGc induced Smurf1 degradation through the 20S proteasome in
a ubiquitin- and ATP-independent manner. As a control, His-CKIP-1
protein could not be degraded by the REGc-proteasome (lanes 5
Fig. 2. REGc promotes the degradation of Smurf1. (A) Smurf1 has no effect on the protein stability of REGc. MCF7 cells were transfected with Myc-REGc and Flag-Smurf1 as
indicated, and was analyzed by IB with anti-Myc and anti-Flag antibodies. The downregulation of Smad5 by Smurf1 was as a positive control. GAPDH was analyzed as an
internal control. (B) Overexpression of REGc decreases the endogenous Smurf1 protein level in a dose-dependent manner rather than its mRNA level. MCF7 cells were
transfected with the increasing amount of REGc, and cell lysates were analyzed by immunoblotting with anti-Smurf1 antibody (left). The p21 protein was a known substrate
for REGc. The Smurf1 mRNA prepared from the REGc-transfected MCF7 cells was analyzed by real-time PCR assay (right). Data are presented as means ± S.E.D (S.E.D., n = 3).
(C) Depletion of REGc increases the endogenous Smurf1 protein level but not its mRNA level. MCF7 cells were transfected with the REGc-speciﬁc siRNAs, and cell lysates were
analyzed by immunoblotting with anti-Smurf1 antibody (left). The Smurf1 mRNA prepared from the REGc siRNA-transfected MCF7 cells was analyzed by real-time PCR assay
(right). Data are presented as means ± S.E.D. (n = 3). (D) Treatment with the proteasome inhibitor MG132 blocks the REGc-mediated turnover of endogenous Smurf1 protein.
MCF7 cells were transfected with Myc-REGc, and treated with MG132 (20 lM) as indicated for 8 h before harvest. Endogenous Smurf1 level was analyzed by IB. (E) REGc
decreases the protein level of both wild-type (WT) and E3 ligase inactive mutant C699A (CA). MCF7 cells were transfected with Myc-Smurf1 (WT or CA) and Flag- REGc as
indicated, and cell lysates were analyzed by IB. (F) REGcmediates Smurf1 degradation by the 20S proteasome in vitro. Puriﬁed REGc, 20S proteasome, and His-Smurf1 or His-
CKIP-1 were incubated for 30 min in vitro, and samples were analyzed by IB as described in Section 2. His-CKIP-1 was used as a negative control. (G) The effect of REGc on
Smurf1 stability relied on its 20S proteasome activation ability. MCF7 cells were transfected with wild-type (WT) REGc or N151Y mutants, and cell lysates were analyzed by
IB with anti-Smurf1 antibody.
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stability.
To further test our hypothesis that REGc modulates Smurf1
expression by activation of 20S proteasome, we generated a mu-
tant REGc-N151Y, which lost the ability to activate the proteasome
although it retained the capacity of binding to the proteasome
[11,12]. As shown in Fig. 2G, the REGc-N151Y mutant lost the abil-
ity to degrade endogenous Smurf1 and slightly increased the
Smurf1 level which might be caused by the dominant-negative ef-
fect of N151Y on endogenous REGc, although its expression level
was comparable with the wild-type REGc. Therefore, REGc acceler-
ated the degradation of Smurf1 dependently of the proteasome.
3.4. Smurf1 recruits its substrates to the REGc proteasome for
degradation
It is recognized that Smurf1 recruits its substrates to the 26S
proteasome for degradation. We ask whether Smurf1 could medi-ate its substrates to the REGc proteasome for degradation, since
that Smurf1 itself could be regulated by the REGc-mediated degra-
dation pathway. Strikingly, we observed that REGc but not the
N151Y mutant promoted the degradation of Smad5, a well-deﬁned
substrate for Smurf1 (Fig. 3A, lanes 1–3). Moreover, Smurf1 and
REGc had the synergic function on Smad5 regulation (Fig. 3A, lane
5 vs. lanes 2 and 4).
Importantly, the decreasing effect of REGc on Smad5 protein le-
vel was largely relied on Smurf1, since that when endogenous
Smurf1 expression was depleted by transfection with Smurf1-spe-
ciﬁc siRNA, REGc lost the ability to promote the turnover of Smad5
(Fig. 3B). In addition, the interaction between REGc and Smad5
could not be detectable until Smurf1 was introduced into the cells
(Fig. 3C). In the presence of Smurf1, both Smad5 and Smurf1 could
be co-immunoprecipitated with REGc (Fig. 3C, lane 8). Smurf1 is
known to bind its substrates via the WW domains. To clarify
whether both REGc and Smad5 bind to the same region of Smurf1,
we next mapped the binding region of Smurf1 with REGc. As seen
Fig. 3. Smurf1 mediates the degradation of Smad5 via the REGc-20S proteasome system. (A) REGc promotes the turnover of Smad5 protein. MCF7 cells were transfected with
Myc-Smad5, Flag- REGc (WT or N151Y), Flag-Smurf1 or together as indicated, and cell lysates were analyzed by IB with anti-Myc and anti-Flag antibodies. (B) The effect of
REGc on Smad5 stability is dependent on Smurf1. MCF7 cells were transfected with Myc-Smad5, Flag-REGc, control siRNAs or Smurf1 siRNAs as indicated, and were analyzed
by IB. (C) Smurf1, Smad5, REGc form a complex. HEK293T cells were transfected with Myc-Smurf1, Myc-Smad5, and Flag-REGc N151Y mutant as indicated, and Co-IP assays
were performed. Both the lysate and the immunoprecipitates samples were analyzed. To avoid the interference of IgG heavy chain on Smad5 detection, HRP-conjugated Myc
antibody was used. IgG LC, IgG light chain. (D) Mapping the REGc-binding region on Smurf1. The indicated Myc-tagged Smurf1 deletion mutants and Flag-REGc N151Y were
cotransfected into HEK293T cells and Co-IP assays were performed. Both the lysate and the immunoprecipitates samples were analyzed. (E) REGc speciﬁcally regulates the
stability of Smad1/3/5 protein but not that of Smad4. MCF7 cells were transfected the indicated Myc-Smads protein and Flag-REGc, and cell lysates were analyzed by IB.
J. Nie et al. / FEBS Letters 584 (2010) 3021–3027 3025in Fig. 3D, both the WW domain and the HECT domain could medi-
ate the interaction between Smurf1 and REGc. Thus, Smurf1,
Smad5 and REGc form a ternary complex, through which Smurf1
recruits Smad5 to the REGc proteasome for degradation.
We next examined the effect of REGc on the stability of other
Smads. Smurf1 is inclined to increase the degradation of Smad1/
5, while its close member Smurf2 promotes the degradation of
Smad2/3, and Smurf1/2 does not target Smad4 for degradation.
Western blot analysis showed that all of the examined Smurf1/2
substrates, i.e. Smad1/3/5, were dramatically downregulated by
REGc, while the protein level of Smad4 was unchanged (Fig. 3E).
3.5. REGc speciﬁcally accelerates the turnover of Smurf1 and Smurf2
among the Nedd4 family of E3 ligases
Smurf1 belongs to the Neural precursor cell-expressed develop-
mentally downregulated gene 4 (Nedd4) family of ubiquitin ligases
and possesses similar C2-WW-HECT organization pattern to other
eight mammalian members, among which Smurf2 exhibits the
highest homology to Smurf1. The fact that Smad3, the known sub-
strate of Smurf2, was downregulated by REGc (Fig. 3E) prompted
us to speculate whether the REGc-proteasome system could target
Smurf2 and/or other members of Nedd4 family for degradation.
REGc was coexpressed with each of the member of Nedd4 familyand the protein levels of the Nedd4 E3s were analyzed by Western
blot. We observed that REGc promoted the degradation of Smurf2
in a dose dependent way (Fig. 4A), but had no signiﬁcant effects on
the expression of WWP1, WWP2, AIP4/Itch, Nedd4-1, Nedd4-2,
NEDL1 or NEDL2 (Fig. 4B–E). Moreover, accordant with the case
of Smurf1, REGc wild-type decreased but N151Y mutant slightly
increased the protein levels of endogenous Smurf2 in MCF7 cells
(Fig. 4F), suggesting that Smurf2 was targeted by the REGc-protea-
some system for degradation in a similar manner to Smurf1.
4. Discussion
The HECT domain-type Nedd4 family E3s are involved in vari-
ous cellular events, including regulation the stability and trafﬁck-
ing of many receptors, channels, signal transducers and viral
proteins [30,31]. Smurf1 is crucial for bone homeostasis via sup-
pressing osteoblast activity, and targets BMP signalling proteins,
Smad1/5, and MEKK2, RhoA for ubiquitination and degradation
by 26S proteasome [22–25,32]. We previously revealed that the
ubiquitin ligase activity of Smurf1 could be activated by binding
to its auxiliary factor CKIP-1. CKIP-1 speciﬁcally interacts with
Smurf1 through the linker region between two WW domains of
Smurf1, enhanced the interaction of Smurf1 with its substrate
and promoted the substrate ubiquitination and degradation [28].
Fig. 4. REGc speciﬁcally accelerates the turnover of Smurf1 and Smurf2 among the Nedd4 family of E3 ligases. (A–E) The effect of REGc on Nedd4 E3s. MCF7 cells were
transfected with Myc-REGc and the Nedd4 family members: Flag-Smurf2 (A), Myc-WWP2 (B), Flag-WWP1/AIP4 (C), Flag-Nedd4–1/Nedd4–2 (D), and Flag-NEDL1/NEDL2 (E),
and cell lysates were analyzed by IB. (F) The effect of REGc on Smurf2 stability relied on its 20S proteasome activation ability. MCF7 cells were transfected with wild-type
(WT) REGc or N151Y mutant, and cell lysates were analyzed by IB with anti-Smurf2 antibody.
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largely unclear. In this study, through yeast two-hybrid screening,
a novel interaction of Smurf1 with the proteasome activator REGc
was identiﬁed and validated both in vivo and in vitro (Fig. 1). The
unique characteristic of REGc is that it promotes protein degrada-
tion independently of ubiquitin and ATP. We showed that Smurf1
was targeted by the REGc-proteasome system for degradation
independently of ubiquitin and ATP (Fig. 2F). Notably, neither
REGc alone nor the 20S core proteasome mediated the degradation
of Smurf1. Consistent with this notion, we observed that REGc-
N151Y mutant which lost the ability to activate the 20S protea-
some could not downregulate the level of Smurf1 (Fig. 2G). These
data implicated that the REGc coordinated with the 20S core pro-
teasome to control the Smurf1 degradation. As far as we know, this
is the ﬁrst direct evidence to establish the relationship between
Nedd4 family ligases and the proteasome system.
As a typical ubiquitin ligase, Smurf1 is expected to be degraded
through the 19S proteasome activator-mediated mechanism. Our
present study does not rule out this possibility. Interestingly, in
our yeast two-hybrid screening, we also obtained a subunit of
the 19S regulatory particle as a potential Smurf1-interacting pro-
tein and the interaction was also validated in mammalian cells
(our unpublished data). We proposed that Smurf1 (and its sub-
strates) might be delivered to the proteasome system both in the
ubiquitin-dependent typical pathway which depends on the 19S
regulatory particle, and in the ubiquitin-independent atypical
pathway which depends on the 11S REGc activator. This dual deg-
radation mechanism is not surprising since that the REGc substrate
p21 also utilizes both the ubiquitin-dependent [33,34] and the
ubiquitin-independent manners [11,12].We also noted that the REGc-proteasome system is mainly
localized in the nucleus. Smurf1 protein could shuttle between
the nucleus and the cytoplasm. Its substrates were distributed
throughout the distinct cellular compartments dependent on the
physiological conditions. Smad1/5 could shuttle between the cyto-
plasm and the nucleus, like Smurf1, and might be targeted to the
REGc proteasome through interaction with Smurf1. Intriguingly,
we detected that Smad1/5 could be easily downregulated by REGc
dependently of the proteasome-activating activity (Fig. 3A and E).
However, the interaction between Smad5 and REGc could not be
detectable until Smurf1 was introduced (Fig. 3C). Depletion of
endogenous Smurf1 almost completely blocked the downregula-
tion of Smad5 by REGc (Fig. 3B). Based on these data, we proposed
a model that Smurf1 interacts directly with REGc and recruits both
itself and its substrates such as Smad1/5 to the REGc-proteasome
for degradation. The ﬁnding that REGc plays a role on the stability
control of Smurf1/2 and Smads raises further questions. For exam-
ples, whether the REGc-mediated degradation of Smurf1/2-Smads
is regulated by BMP/TGF-b signalling? How is the physiological
role of REGc in mediating the degradation of Smurf1/2 and Smads
protein? Both questions are worthy of further investigations.
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